Two of seven patients in Global Blood Therapeutics Inc. (Nasdaq: GBT) study of voxelotor died. The stock price plummeted $6.38 to close at $38.40.
Patients die in Global Blood Therapeutics study
December 12, 2017 at 18:09 PM EST
Patients die in Global Blood Therapeutics studyDecember 12, 2017 at 18:09 PM EST
Two of seven patients in Global Blood Therapeutics Inc. (Nasdaq: GBT) study of voxelotor died. The stock price plummeted $6.38 to close at $38.40. Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|